Ignite Creation Date:
2024-05-05 @ 9:08 PM
Last Modification Date:
2024-10-26 @ 9:59 AM
Study NCT ID:
NCT00810017
Status:
TERMINATED
Last Update Posted:
2022-05-19
First Post:
2008-12-16
Brief Title:
Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
Sponsor:
Medstar Health Research Institute
Organization:
Medstar Health Research Institute
Organization Data
Organization:
Medstar Health Research Institute
Class:
OTHER
Study ID:
IIT_H446Us
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medstar Health Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |